NCT01666587View on ClinicalTrials.gov

Ischemia Reperfusion: Prostaglandins and Antioxidants

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Ischemic Reperfusion Injury
Interventions
DIETARY_SUPPLEMENT

Antioxidant

DRUG

Prostaglandin inhibitor (Ibuprophen)

Trial Locations (1)

CO4 3SQ

University of Essex, Colchester

All Listed Sponsors
lead

University of Essex

OTHER

NCT01666587 - Ischemia Reperfusion: Prostaglandins and Antioxidants | Biotech Hunter | Biotech Hunter